Works matching IS 0893133X AND DT 2004 AND VI 29 AND IP 3

Results: 25

Unbalanced Statistical Analysis of Combined Divalproex and Antipsychotic Therapy for Schizophrenia.

Published in:

2004

By:

Boylan, Laura S.;
Labovitz, Daniel L.

Publication type:

Letter

Presynaptic Modulation of Spontaneous Inhibitory Postsynaptic Currents by Gamma-hydroxybutyrate in the Substantia Nigra Pars Compacta.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 537, doi. 10.1038/sj.npp.1300344

By:

Brancucci, Alfredo;
Berretta, Nicola;
Mercuri, Nicola B.;
Francesconi, Walter

Publication type:

Article

Regulation of Platelet α2A-Adrenoceptors, Gi Proteins and Receptor Kinases in Major Depression: Effects of Mirtazapine Treatment.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 580, doi. 10.1038/sj.npp.1300356

By:

Garcia-Sevilla, Jesú A.;
Ventayol, Pedro;
Pérez, Victor;
Rubovszky, Grégoire;
Puigdemont, Dolors;
Ferrer-Alcón, Marcel;
Andreoli, Antonio;
Guimón, José;
Alvarez, Enric

Publication type:

Article

Family Psychopathology and Magnitude of Reductions in Occipital Cortex GABA Levels in Panic Disorder.

Published in:

2004

By:

Goddard, Andrew W.;
Mason, Graeme F.;
Rothman, Douglas L.;
Behar, Kevin L.;
Petroff, Ognen A.C.;
Krystal, John H.

Publication type:

Letter

Reply: Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia.

Published in:

2004

By:

Casey, Daniel E.;
Daniel, David G.;
Wassef, Adel A.;
Tracy, Katherine A.;
Wozniak, Patricia;
Sommerville, Kenneth W.

Publication type:

Letter

ATF2, A Member of the CREB/ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 589, doi. 10.1038/sj.npp.1300357

By:

Laifenfeld, D.;
Karry, R.;
Grauer, E.;
Klein, E.;
Ben-Shachar, D.

Publication type:

Article

Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 558, doi. 10.1038/sj.npp.1300311

By:

Hamilton, Steven P.;
Slager, Susan L.;
de Leon, Ada Baisre;
Heiman, Gary A.;
Klein, Donald F.;
Hodge, Susan E.;
Weissman, Myrna M.;
Fyer, Abby J.;
Knowles, James A.

Publication type:

Article

Adenosine A1 Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 544, doi. 10.1038/sj.npp.1300351

By:

Okamura, Naoe;
Hashimoto, Kenji;
Shimizu, Eiji;
Kumakiri, Chikara;
Komatsu, Naoya;
Iyo, Masaomi

Publication type:

Article

Using fMRI to Quantify the Time Dependence of Remifentanil Analgesia in the Human Brain.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 626, doi. 10.1038/sj.npp.1300364

By:

Wise, Richard G.;
Williams, Pauline;
Tracey, Irene

Publication type:

Article

Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 619, doi. 10.1038/sj.npp.1300367

By:

Katerina, Zavitsanou;
Andrew, Katsifis;
Filomena, Mattner;
Huang Xu-Feng, Mattner

Publication type:

Article

Independent Evaluator Knowledge of Treatment in a Multicenter Comparative Treatment Study of Panic Disorder.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 612, doi. 10.1038/sj.npp.1300373

By:

Roll, David;
Ray, Susan E.;
Marcus, Sue M.;
Passarelli, Vincent;
Money, Roy;
Barlow, David H.;
Woods, Scott W.;
Shear, M. Katherine;
Gorman, Jack M.

Publication type:

Article

Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 605, doi. 10.1038/sj.npp.1300365

By:

Pomara, Nunzio;
Willoughby, Lisa M.;
Ritchie, James C.;
Sidtis, John J.;
Greenblatt, David J.;
Nemeroff, Charles B.

Publication type:

Article

Acute Cortisol Administration Promotes Sleep Intensity in Man.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 598, doi. 10.1038/sj.npp.1300362

By:

Friess, Elisabeth;
Tagaya, Hirokuni;
Grethe, Claus;
Trachsel, Lorenz;
Holsboer, Florian

Publication type:

Article

Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of G5α.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 494, doi. 10.1038/sj.npp.1300309

By:

Gould, Thomas J.;
Bizily, Scott P.;
Tokarczyk, Jan;
Kelly, Michele P.;
Siegel, Steven J.;
Kanes, Stephen J.;
Abel, Ted

Publication type:

Article

Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 566, doi. 10.1038/sj.npp.1300341

By:

Katz, Martin M.;
Tekell, Janet L.;
Bowden, Charles L.;
Brannan, Steve;
Houston, John P.;
Berman, Nancy;
Frazer, Alan

Publication type:

Article

Olanzapine Penetration into Brain is Greater in Transgenic Abcb P-glycoprotein-Deficient Mice than FVBI (Wild-Type) Animals.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 551, doi. 10.1038/sj.npp.1300372

By:

Jun-Sheng Wang;
Taylor, Robin;
Ying Ruan, Robin;
Donovan, Jennifer L.;
Markowitz, John S.;
De Vane, C. Lindsay

Publication type:

Article

Acetaldehyde Increases Dopaminergic Neuronal Activity in the VTA.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 530, doi. 10.1038/sj.npp.1300326

By:

Foddai, Marzia;
Dosia, Gabriella;
Spiga, Saturnino;
Diana, Marco

Publication type:

Article

Repeated, Intermittent Δ9-Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visusospatial Divided Attention.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 522, doi. 10.1038/sj.npp.1300316

By:

Verrico, Christopher D.;
Jentsch, J. David;
Roth, Robert H.;
Taylor, Jane R.

Publication type:

Article

In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 514, doi. 10.1038/sj.npp.1300322

By:

Wierońska, Joanna M.;
Śmialowska, Maria;
Brański, Piotr;
Gasparini, Fabrizio;
Klodzińska, Aleksandra;
Szewczyk, Bernadeta;
Palucha, Agienszka;
Chojnacka-Wójcik, Ewa;
Pilc, Andrzej

Publication type:

Article

Anxiolytic Activity of the MGLU2/3 Receptor Agonist LY354740 on the Elevated Plus Maze is Associated with the Suppression of Stress-Induced c-Fos in the Hippocampus and Increases in c-Fos Induction in Several Other Stress-Sensitive Brain Regions.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 502, doi. 10.1038/sj.npp.1300321

By:

Linden, A.-M.;
Greene, S.J.;
Bergeron, M.;
Schoepp, D.D.

Publication type:

Article

Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin VIa Receptor Knockout Mice.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 483, doi. 10.1038/sj.npp.1300360

By:

Bielsky, Isadora F.;
Shuang-Bao Hu, Isadora F.;
Szegda, Kathleen L.;
Westphal, Heiner;
Young, Larry J.

Publication type:

Article

Stress Sensitization of Ethanol Withdrawal-Induced Reduction in Social Interaction: Inhibition by CRF-I and Benzodiazepine Receptor Antagonists and a 5-HT1A-Receptor Agonist.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 470, doi. 10.1038/sj.npp.1300282

By:

Breese, George R.;
Knapp, Darin J.;
Overstreet, David H.

Publication type:

Article

Diabetes Attenuates the Antidepressant-Like Effect Mediated by the Activation of 5-HT1A Receptor in the MOuse Tail Suspension Test.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 461, doi. 10.1038/sj.npp.1300354

By:

Miyata, Shigeo;
Hirano, Shoko;
Kamei, Junzo

Publication type:

Article

Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 450, doi. 10.1038/sj.npp.1300320

By:

Banasr, Mounira;
Hery, Micheline;
Printemps, Richard;
Daszuta, Annie

Publication type:

Article

Role of H3-Receptor-Mediated Signaling in Anxiety and Cognition in Wild-Type and Apoe-/- Mice.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 3, p. 441, doi. 10.1038/sj.npp.1300352

By:

Bongers, Gerald;
Leurs, Rob;
Robertson, Jennifer;
Raber, Jacob

Publication type:

Article

Works matching IS 0893133X AND DT 2004 AND VI 29 AND IP 3

Unbalanced Statistical Analysis of Combined Divalproex and Antipsychotic Therapy for Schizophrenia.

Presynaptic Modulation of Spontaneous Inhibitory Postsynaptic Currents by Gamma-hydroxybutyrate in the Substantia Nigra Pars Compacta.

Regulation of Platelet α<sub>2A</sub>-Adrenoceptors, Gi Proteins and Receptor Kinases in Major Depression: Effects of Mirtazapine Treatment.

Family Psychopathology and Magnitude of Reductions in Occipital Cortex GABA Levels in Panic Disorder.

Reply: Effect of Divalproex Combined with Olanzapine or Risperidone in Patients with an Acute Exacerbation of Schizophrenia.

ATF2, A Member of the CREB/ATF Family of Transcription Factors, in Chronic Stress and Consequent to Antidepressant Treatment: Animal Models and Human Post-Mortem Brains.

Evidence for Genetic Linkage Between a Polymorphism in the Adenosine 2A Receptor and Panic Disorder.

Adenosine A<sub>1</sub> Receptor Agonists Block the Neuropathological Changes in Rat Retrosplenial Cortex after Administration of the NMDA Receptor Antagonist Dizocilpine.

Using fMRI to Quantify the Time Dependence of Remifentanil Analgesia in the Human Brain.

Investigation of M1/M4 Muscarinic Receptors in the Anterior Cingulate Cortex in Schizophrenia, Bipolar Disorder, and Major Depression Disorder.

Independent Evaluator Knowledge of Treatment in a Multicenter Comparative Treatment Study of Panic Disorder.

Interdose Elevation in Plasma Cortisol During Chronic Treatment with Alprazolam but not Lorazepam in the Elderly.

Acute Cortisol Administration Promotes Sleep Intensity in Man.

Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of G<sub>5</sub>α.

Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression.

Olanzapine Penetration into Brain is Greater in Transgenic Abcb P-glycoprotein-Deficient Mice than FVBI (Wild-Type) Animals.

Acetaldehyde Increases Dopaminergic Neuronal Activity in the VTA.

Repeated, Intermittent Δ<sup>9</sup>-Tetrahydrocannabinol Administration to Rats Impairs Acquisition and Performance of a Test of Visusospatial Divided Attention.

In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling.

Anxiolytic Activity of the MGLU2/3 Receptor Agonist LY354740 on the Elevated Plus Maze is Associated with the Suppression of Stress-Induced c-Fos in the Hippocampus and Increases in c-Fos Induction in Several Other Stress-Sensitive Brain Regions.

Profound Impairment in Social Recognition and Reduction in Anxiety-Like Behavior in Vasopressin VIa Receptor Knockout Mice.

Stress Sensitization of Ethanol Withdrawal-Induced Reduction in Social Interaction: Inhibition by CRF-I and Benzodiazepine Receptor Antagonists and a 5-HT<sub>1A</sub>-Receptor Agonist.

Diabetes Attenuates the Antidepressant-Like Effect Mediated by the Activation of 5-HT<sub>1A</sub> Receptor in the MOuse Tail Suspension Test.

Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone.

Role of H<sub>3</sub>-Receptor-Mediated Signaling in Anxiety and Cognition in Wild-Type and Apoe<sup>-/-</sup> Mice.